An ex-firefighter with ties to RFK Jr. is leading the federal agency that handles public health crises and maintains the ...

Moderna’s market value has fallen by more than 90% — $185 billion, or a full Sony — from its 2021 peak to around $10 billion ...

CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they ...

For cancer patients, administration of a COVID-19 vaccine within 100 days of ICI initiation was associated with increased overall survival.

A recent Associated Press investigation revealing hundreds of anti-science bills across the United States anchors this ...

Supported by the Center for Infectious Disease Research and Policy's (CIDRAP) Vaccine Integrity Project (VIP), the ...

This fall, with measles cases still spreading, there’s an additional challenge on top of the usual viral threat posed by COVID-19, RSV, influenza and the common cold. Here is the latest medical advice ...

Victorian researchers have developed a world-first RNA drug for lupus, an auto-immune disease that affects around 20,000 ...

How deep will the anti-science MAHA invasion penetrate into Mississippi? Can beleaguered state health officer Dr. Daniel ...

Moderna ($MRNA) stock jumped 17% on Thursday, fueled by speculation of potential buyout talks amid concerns over declining ...

Moderna (NASDAQ:MRNA) stock surged as much as 12% Thursday following a STAT News report that the COVID-19 vaccine maker has been in discussions with at least one large pharmaceutical company about "a ...

Pfizer Inc. (NYSE:PFE) is one of the most undervalued large cap stocks to buy right now. On October 24, Pfizer Singapore and ...